Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Return on Assets: 2011-2025

Historic Return on Assets for Ironwood Pharmaceuticals (IRWD) over the last 14 years, with Sep 2025 value amounting to 0.35%.

  • Ironwood Pharmaceuticals' Return on Assets rose 94.00% to 0.35% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.35%, marking a year-over-year increase of 94.00%. This contributed to the annual value of 0.25% for FY2024, which is 185.00% up from last year.
  • Ironwood Pharmaceuticals' Return on Assets amounted to 0.35% in Q3 2025, which was up 25.82% from 0.28% recorded in Q2 2025.
  • Ironwood Pharmaceuticals' Return on Assets' 5-year high stood at 0.63% during Q2 2021, with a 5-year trough of -2.88% in Q1 2024.
  • In the last 3 years, Ironwood Pharmaceuticals' Return on Assets had a median value of -0.53% in 2024 and averaged -0.73%.
  • In the last 5 years, Ironwood Pharmaceuticals' Return on Assets plummeted by 304bps in 2024 and then surged by 308bps in 2025.
  • Quarterly analysis of 5 years shows Ironwood Pharmaceuticals' Return on Assets stood at 0.48% in 2021, then plummeted by 32bps to 0.16% in 2022, then plummeted by 269bps to -2.53% in 2023, then skyrocketed by 281bps to 0.28% in 2024, then skyrocketed by 94bps to 0.35% in 2025.
  • Its last three reported values are 0.35% in Q3 2025, 0.28% for Q2 2025, and 0.21% during Q1 2025.